- Home
- OABI vs LARK Comparison
OABI vs LARK Comparison
Compare OABI & LARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- LARK
- Stock Information
- Founded
- OABI 2012
- LARK 1885
- Country
- OABI United States
- LARK United States
- Employees
- OABI N/A
- LARK N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- LARK Major Banks
- Sector
- OABI Health Care
- LARK Finance
- Exchange
- OABI Nasdaq
- LARK Nasdaq
- Market Cap
- OABI 198.2M
- LARK 167.5M
- IPO Year
- OABI N/A
- LARK N/A
- Fundamental
- Price
- OABI $1.93
- LARK $28.25
- Analyst Decision
- OABI Strong Buy
- LARK
- Analyst Count
- OABI 3
- LARK 0
- Target Price
- OABI $7.00
- LARK N/A
- AVG Volume (30 Days)
- OABI 912.8K
- LARK 47.0K
- Earning Date
- OABI 08-07-2025
- LARK 08-04-2025
- Dividend Yield
- OABI N/A
- LARK 3.02%
- EPS Growth
- OABI N/A
- LARK 27.69
- EPS
- OABI N/A
- LARK 2.59
- Revenue
- OABI $26,744,000.00
- LARK $60,798,000.00
- Revenue This Year
- OABI N/A
- LARK N/A
- Revenue Next Year
- OABI $45.65
- LARK N/A
- P/E Ratio
- OABI N/A
- LARK $10.46
- Revenue Growth
- OABI 27.07
- LARK 9.30
- 52 Week Low
- OABI $1.22
- LARK $18.19
- 52 Week High
- OABI $4.96
- LARK $31.04
- Technical
- Relative Strength Index (RSI)
- OABI 69.01
- LARK 51.01
- Support Level
- OABI $1.55
- LARK $24.70
- Resistance Level
- OABI $1.73
- LARK $25.20
- Average True Range (ATR)
- OABI 0.10
- LARK 0.91
- MACD
- OABI 0.03
- LARK 0.12
- Stochastic Oscillator
- OABI 100.00
- LARK 71.37
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About LARK Landmark Bancorp Inc.
Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.